Triangle Coviracil NDA Slated For September; Abbott Bows Out As Partner

Triangle Pharmaceuticals will file an NDA for Coviracil in September without a marketing partner following the reacquisition of rights to the nucleoside reverse transcriptase inhibitor from Abbott